A Retrospective Review: Outcomes of the REFLECT™ System for Idiopathic Scoliosis

May 11, 2026 updated by: Globus Medical Inc

A Retrospective Review of Clinical and Radiographic Outcomes Following the Use of the REFLECT™ Scoliosis Correction System in the Treatment of Idiopathic Scoliosis

This study reviews medical records of children and adolescents treated for idiopathic scoliosis (a sideways curve of the spine with no known cause) using the REFLECT™ Scoliosis Correction System.

Study Overview

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Simmerath
      • Simmerath, Simmerath, Germany, 52152
        • Eifel Clinic St. Brigida GmbH & Co. KG
        • Contact:
        • Principal Investigator:
          • Per Trobisch, MD
    • I
      • Istanbul, I, Turkey (Türkiye), 34457
        • Acibadem Maslak Hospital
        • Principal Investigator:
          • Ahmet Alanay, MD
        • Contact:
    • New York
      • New York, New York, United States, 11554
        • NYU Langone Orthopedic Center
        • Contact:
        • Principal Investigator:
          • Juan C Rodriguez-Olaverri, MD, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The study population consists of skeletally immature pediatric and adolescent patients with progressive idiopathic scoliosis who were treated surgically with the REFLECT™ Scoliosis Correction System as part of routine clinical care. Eligible patients had a major spinal curve between 30° and 65°, required surgical correction after failing or being unable to tolerate bracing, and had adequate bone quality to support screw fixation.

This is a multicenter, international retrospective cohort including approximately 100 patients treated at participating institutions in Germany, Turkey, and the United States. The cohort includes patients treated with either 4.0 mm or 5.0 mm REFLECT cords, using single or dual cords per curve, with at least 12 months of postoperative clinical and radiographic follow-up available for review.

Description

Inclusion Criteria:

Subjects must meet all of the following criteria to be included in the study:

  1. Requires surgical treatment to obtain and maintain correction of idiopathic scoliosis
  2. Skeletally immature
  3. Major Cobb angle of 30° and 65°
  4. Bone structure adequate to safely accommodate screw fixation
  5. Failed bracing treatment and/or intolerant to brace wear
  6. Treated with the REFLECT™ Scoliosis Correction System, using single or dual REFLECT cord(s) per curve
  7. Availability of medical and radiographic records evaluating the product under study preoperatively through a minimum of 12 months postoperative

Exclusion Criteria:

Patients were excluded from the study if they met any of the following conditions:

  1. Presence of any systemic infection, local infection, or skin compromise at the surgical site
  2. Prior spinal surgery at the level(s) to be treated
  3. Known poor bone quality, defined as a T-score of -1.5 or less
  4. Any other medical or surgical condition which would preclude the potential benefit of spinal surgery, such as coagulation disorders, allergies to the implant materials, or patient unwillingness or inability to cooperate with postoperative care instructions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
4.0 Group
4.0 mm diameter REFLECT cords were used to treat patients.
The REFLECT system is a non-fusion spinal device, meaning it corrects scoliosis without permanently fusing the spine. Instead of rigid metal rods, it uses a flexible polymer cord attached to screws. For this intervention, a 4.0 mm cord diameter was used to treat patients.
The REFLECT system is a non-fusion spinal device, meaning it corrects scoliosis without permanently fusing the spine. Instead of rigid metal rods, it uses a flexible polymer cord attached to screws. For this intervention, a 5.0 mm cord diameter was used to treat patients.
5.0 Group
5.0 mm diameter REFLECT cords were used to treat patients.
The REFLECT system is a non-fusion spinal device, meaning it corrects scoliosis without permanently fusing the spine. Instead of rigid metal rods, it uses a flexible polymer cord attached to screws. For this intervention, a 4.0 mm cord diameter was used to treat patients.
The REFLECT system is a non-fusion spinal device, meaning it corrects scoliosis without permanently fusing the spine. Instead of rigid metal rods, it uses a flexible polymer cord attached to screws. For this intervention, a 5.0 mm cord diameter was used to treat patients.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
REFLECT Cord Breakage/Separation
Time Frame: by latest available time point (minimum 12 months postoperative)
Comparison of REFLECT cord breakage/separation rate (radiographically suspected or confirmed) in 4.0 mm vs. 5.0 mm cords
by latest available time point (minimum 12 months postoperative)
Subsequent Surgeries Related to Cord Breakage
Time Frame: by latest available time point (minimum 12 months postoperative)
Rate of subsequent surgeries at the treatment levels associated with REFLECT cord breakage/separation
by latest available time point (minimum 12 months postoperative)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complications Profile
Time Frame: up to the latest available follow-up visit, with a required minimum of 12 months after surgery.
Rate of all complications attributable to the REFLECT system
up to the latest available follow-up visit, with a required minimum of 12 months after surgery.
All Subsequent Surgeries
Time Frame: up to the latest available follow-up visit, with a required minimum of 12 months after surgery.
Rate of all subsequent surgeries at the treatment levels that are associated with the REFLECT system
up to the latest available follow-up visit, with a required minimum of 12 months after surgery.
Change in Curve
Time Frame: From baseline (preoperative) to each postoperative time point.
Change in curve(s), as measured by the change in Cobb angle(s)
From baseline (preoperative) to each postoperative time point.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 15, 2026

Primary Completion (Estimated)

January 30, 2027

Study Completion (Estimated)

July 31, 2027

Study Registration Dates

First Submitted

May 5, 2026

First Submitted That Met QC Criteria

May 11, 2026

First Posted (Actual)

May 15, 2026

Study Record Updates

Last Update Posted (Actual)

May 15, 2026

Last Update Submitted That Met QC Criteria

May 11, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Idiopathic Scoliosis

Clinical Trials on Scoliosis Correction System

Subscribe